The lab-tracked-care library.
A clinical practice publishes education not as marketing but because informed patients consent better. These pages explain what Vayra prescribes, how it works, what it costs, and where the evidence does, and does not, yet reach.
Peptide therapy overview
How Vayra approaches peptide therapy, clinical scope, regulatory framework, and why prescribing is the outcome of a documented physician encounter, not a product menu.
ReadGLP-1 weight optimization
Branded Wegovy®, Zepbound®, and Mounjaro®. FDA approvals, dosing schedules, and why our GLP-1 program uses FDA-approved branded medication rather than compounded semaglutide or tirzepatide.
ReadWhat we measure, and why
The baseline and follow-up panels Vayra physicians order, read in plain language, interpreted clinically at your visit.
ReadCare glossary
503A, GLP-1, PHQ-2, SERM, Insights Program, the terminology you'll encounter at Vayra, defined in one place.
ReadReady to begin?
Your assessment is eight minutes. Continuity is a priority, you will see the same physician whenever clinically possible. Private clinical practice, we do not bill insurance.
Begin assessment